Home › Funds › BlackRock Inc › FATE
BlackRock Inc position in FATE
FATE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)7.30M sh
Reported value held$19.71M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 10.47M | $36.66M | New |
| Q4 2024 | 10.94M | $18.05M | Add |
| Q1 2025 | 10.68M | $8.44M | Reduce |
| Q2 2025 | 10.81M | $12.11M | Add |
| Q3 2025 | 10.68M | $13.46M | Reduce |
| Q4 2025 | 10.18M | $10.00M | Reduce |
| Q1 2026 | 10.07M | $12.08M | Reduce |
| Q2 2026 | 7.30M | $19.71M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FATE
- AQR Capital Management 3.84M sh · $10.36M · Q2 2026
- Two Sigma Investments 3.59M sh · $9.69M · Q2 2026
- Vanguard Group 8.97M sh · $8.82M · Q4 2025
- Renaissance Technologies 2.98M sh · $8.05M · Q2 2026
- Millennium Management 2.43M sh · $6.57M · Q2 2026
- Goldman Sachs Group 2.05M sh · $5.53M · Q2 2026
- Geode Capital Management 1.32M sh · $3.57M · Q2 2026
- Citadel Advisors 1.09M sh · $2.95M · Q2 2026
- Morgan Stanley 694.58K sh · $1.88M · Q2 2026
- Charles Schwab Investment Management 610.95K sh · $1.65M · Q2 2026
- UBS Group AG 590.18K sh · $1.59M · Q2 2026